The Agencies and the Commission should be able to process human biomonitoring data constituting personal data to assess the impact of chemicals on human health and the environment, to monitor time and spatial trends in exposure, to assess the need for regulatory action and prioritise such action, to monitor the impact of regulatory action, and to support policy making and the development of legislation, including by carrying out scientific research for those purposes. In addition, taking into account their mission and activities, the EEA, the ECHA, the EFSA, EU-OSHA and the Commission should be able to process human biomonitoring data constituting personal data to develop health risk and impact indicators, the ECHA, the EFSA and the EMA should be able to process such data to perform regulatory risk assessments and support regulatory risk management, and the EEA, the ECHA, the EFSA and the Commission should be able to process such data in the context of studies under the data generation mechanism established through this Regulation. The EEA and EU-OSHA should also be able to process human biomonitoring data constituting personal data to support regulatory risk assessment and management and the Commission should be able to process such data to perform regulatory risk assessment and management. When processing human biomonitoring data constituting personal data, the Agencies and the Commission should pay particular attention to the need to comply with Article 13 of Regulation (EU) 2018/1725.
Text as published in the Official Journal, reproduced verbatim (including any typographical quirks of the source). For the authentic version, see EUR-Lex.
